9 rue du 4 septembre
75002 Paris, France
Mail : email@example.com
URL : www.mdstart.eu
Accordance with the law n ° 78-17 of 6 January 1978 relating to computers, files and freedoms, individuals have a right to access and correct personal data. This right may be exercised at the Directorate.
AGENCE K2 - Paris
DESIGN & DEVELOPMENT:
AGENCE K2 - Paris
Artistic Director: Nicolas Gauthier
Development: Alexandre Pedro
The use of any document from www.mdstart.eu webpage is only permitted for information and personal use. Reuse, reproduction, transcription or alteration of any part of this website, for other aims, is strictly forbidden, without the following society's prior written permission to: MD START - 9 rue du 4 Septembre - 75002 Paris
ACCESS TO WEBSITE:
MD Start reserves the right to fully or partially alter, cancel, suspend, or interrupt, at anytime, for any reason, and at its own discretion, access to website, including to its content, functionalities, or availability hours, without prior notice.
RESPONSABILITY FOR THE CONTENT:
MD Start tries its best to guarantee the accuracy and updating of the information posted on this website, and reserve right to correct its content, anytime, without prior notice. Users are warned that they are responsible for seeking information through other means, for example by phoning our office. We therefore accept no responsibility: for any imprecision, inaccuracy or omission dealing with information posted on this website; for any damage resulting from fraudulent intrusion of user, having resulted in an alteration of information available on the webpage.
External websites, with hyperlinks to this webpage are not controlled by MD Start, which therefore accepts no responsibility for their content. These hyperlinks are in no way equivalent to approbation or partnership with MD Start, these external websites being subjected to theirownterms and conditions, and their own privacy policies.
The products, brand names, signatures and brand images mentioned on his webpage are owned by their respective companies.